Corporate digest
Tianjin Zhong Xin Pharma
TIANJIN Zhong Xin Pharmaceutical Group Corp saw net profit for the third quarter ended Sept 30 slide 6 per cent year on year to 89.32 million yuan (S$18.4 million).
Meanwhile, revenue for the three-month period fell 10 per cent to 1.49 billion yuan. However, gross profit rose 9 per cent to 473.15 million yuan as cost of sales came down 17 per cent to 1.02 billion yuan. Earnings per share came to 0.12 yuan, down from 0.13 yuan a year ago.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
VinFast’s EV ambitions get a reality check as shares plunge 65%
Stocks to watch: FLCT, Paragon Reit, AA Reit, Lendlease Global Reit, Far East Orchard, SIA
Jefferies asks judge to remove managers of Weiss Multi-Strategy
JPMorgan sees gain of about US$8 billion from Visa exchange offer
BlackRock cuts jobs in muni business under new leadership
Grayscale Bitcoin Trust sees first inflows since US ETFs were approved